All entries for: Cerevel Therapeutics

October 1, 2023

Cerevel Therapeutics

Negative Outlook

Cambridge, MA
201-500 employees
201-500 employees

“The effect of IRA on our business and the healthcare industry in general is not yet fully known. Adoption of price controls and cost-containment measures, and adoption of more restrictive policies in jurisdictions with existing controls and measures, could further limit our revenue generated from the sale of any approved products”

Disease Area: Neurological Diseases
Drug Type: Small Molecule
August 2, 2023

Cerevel Therapeutics

Negative Outlook

Cambridge, MA
201-500 employees
201-500 employees
Disease Area: Neurological Diseases
Drug Type: Small Molecule
May 3, 2023

Cerevel Therapeutics

Negative Outlook

Cambridge, MA
201-500 employees
201-500 employees
Disease Area: Neurological Diseases
Drug Type: Small Molecule
November 8, 2022

Cerevel Therapeutics

Negative Outlook

Cambridge, MA
201-500 employees
201-500 employees

Impact TBD: “The effect of IRA on our business and the healthcare industry in general is not yet known. Adoption of price controls and cost-containment measures, and adoption of more restrictive policies in jurisdictions with existing controls and measures, could further limit a company’s revenue generated from the sale of any approved products. Even if we do receive a favorable coverage determination for our products by third-party payors, coverage policies and third-party payor reimbursement rates may change at any time”

Disease Area: Neurological Diseases
Drug Type: Small Molecule
Scroll to Top